Overall, mutated-β-catenin represses IRF2, POU2F1, and likely other TFs, which limits transcription of key chemokines and cytokines important for priming recruitment of lymphocytes needed for an effective anti-tumor immunity and ICI response. The gene discussed is IRF2; the disease is neoplasm.